Viewing Study NCT00147550


Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2025-12-29 @ 12:28 AM
Study NCT ID: NCT00147550
Status: TERMINATED
Last Update Posted: 2013-09-13
First Post: 2005-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module